"Treatment of preterm labor and primary dysmenorrhea "

Exit 2018

Industry
Biotechnology

Focus
Innovative therapeutics for the treatment of preterm labor and primary dysmenorrhea

Milestones
MIG invests in PDC
2009
Exit
2018